BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

Medical technology company BioNexus Gene Lab Corp. (NASDAQ:BGLC) announced the adoption of Ethereum (CRYPTO: ETH) as a ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

To provide transparency and further insight into this decision, BGLC has published its Ethereum Strategy Whitepaper, which is now available to the public. This document outlines Ethereum’s role as a ...

KINGSTON, Jamaica- The Betting, Gaming and Lotteries Commission (BGLC) is urging operators of unlicensed gaming machines and locations to take advantage of its compliance drive to regularise their ...

1 Day BGLC -2.27% DJIA 1.39% Russell 2K 1.09% Health Care/Life Sciences -0.37% ...

Earnings reports almost always include EPS and Revenue results. BioNexus Gene Lab (BGLC) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November ...

Short interest in BioNexus Gene Lab Corp (NASDAQ:BGLC) increased during the last reporting period, rising from 313.77K to 371.18K. This put 2.11% of the company's publicly available shares short.

1 Day BGLC 0.06% DJIA -1.48% Russell 2K -2.81% Health Care/Life Sciences -0.37% ...

KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.